Jeffrey Tate, Chief Operating Officer at Cyclo Therapeutics, Inc. (CYTH), bought 2,000 shares at $7.50 ($15K) on 2021-03-29, disclosed to the SEC on 2021-03-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CYTH | BUY | 2022-04-29 | $5K | — | Filing → |